Ben Livingston, director of the Center for Legal Cannabis, discusses the legalization anniversary event.» Read More
*Diet drugs and plans a hard sell, despite rising obesity. KALUNDBORG, Denmark, Nov 14- Steam rises from pipes at a giant industrial complex on the edge of the Baltic Sea whose success is a testament to the world's diabetes and obesity epidemic.
An experimental GlaxoSmithKline drug, designed to fight heart disease in a new way, failed to meet its main goal in a major clinical study.
London-listed Shire has agreed to buy U.S. company ViroPharma for about $4.2 billion in cash.
The FDA proposed a new rule that would open up generic drugmakers to liability and apply some of the same regulations used for brand manufacturers.
CNBC's Tyler Mathisen, Jon Fortt and Michelle Caruso-Cabrera debate the money to be made from the legalization of marijuana.
Oct 22- Pfizer Inc said it has decided to develop the abuse-resistant painkiller made by its partner Pain Therapeutics Inc, six months after the pharmaceutical giant's comments raised fears it would drop the drug. Pain Therapeutics shares jumped as much as 30 percent in early trading on the Nasdaq.
Costco says it will cooperate with the Drug Enforcement Administration in its ongoing investigation of prescriptions for controlled substances.
You've heard of ED. Now there's a drug for PE, made by a 4-year-old start-up. It's designed for men to make their mates happier.
Will.i.am talks to CNBC about the "failure" of the Drug Abuse Resistance Education program and how thousands of Americans are now in prison because of lack of opportunities in their neighborhood.
Some 16,651 people in 2010 died from overdose deaths related to opioid abuse, the FDA said, including long-acting formulations. In a conference call, FDA officials said long-acting forms of opioids have played a "disproportionate role" in drug abuse and deaths.
The FDA is expected to decide on whether to fast track Perjeta for early treatment of breast cancer by Oct. 31.
The FDA will highlight on labels the dangers of abuse and possible death, as well as risks to newborns of mothers taking the medicines, it said in a release on Tuesday. The FDA said the drug labels currently are indicated for patients with moderate to severe pain and would in future indicate they should only be used for severe pain.
Biogen Idec has agreed to pay another $100 million upfront to Isis Pharmaceuticals as part of a broad collaboration to develop neurological medicines.
The cannabis legalization trend is creating jobs in states where laws have been relaxed, and big business is "looking into the industry in a big way," an expert says.
Aug 26- Acura Pharmaceuticals Inc said a painkiller made with its abuse-deterrent technology did not show statistically significant results in reducing likability among abusers, sending its shares down as much as 34 percent in extended trading.
A warning about stock scams involving marijuana related companies has been issued; CNBC's Mary Thompson has the story.
FINRA is issuing a new investor alert called "marijuana stock scams." CNBC's Mary Thompson offers insight.
FINRA warned Tuesday that scammers have been targeting investors attempting to tap into the growing U.S. marijuana industry.
Colorado and Washington are trying to figure out a system to regulate and track the use of legalized marijuana, reports CNBC's Jane Wells.
NEW YORK, Aug 15- Kurt is a 32- year-old IT systems administrator from Des Moines, Iowa. Soon Kurt was taking them three to four times a week to get high and relax. One in 10 Americans admit taking a prescription drug they have not been prescribed, and a quarter of those people have used them just to get high, according to an ongoing Reuters/ Ipsos poll.